Atlas Trials

HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease

Clinical trial NCT03240731 · COMPLETED

Trial details

NCT number
NCT03240731
Sponsor
Centre Hospitalier Intercommunal Creteil
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2017-08-10
Primary completion
2024-04-08
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.